昊帆生物
(301393)
| 流通市值：21.62亿 | | | 总市值：57.86亿 |
| 流通股本：4035.90万 | | | 总股本：1.08亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 551,505,762.15 | 361,081,038.91 | 352,522,855.53 | 929,428,407.98 |
| 应收票据及应收账款 | 126,789,462.4 | 97,164,584.32 | 99,133,610.78 | 95,872,320.48 |
| 其中：应收票据 | 10,274,643.87 | 3,951,011.35 | 1,047,433.46 | 2,632,501 |
| 应收账款 | 116,514,818.53 | 93,213,572.97 | 98,086,177.32 | 93,239,819.48 |
| 应收款项融资 | 1,140,664.28 | 1,174,605.89 | 2,078,532.33 | 2,785,405 |
| 预付款项 | 5,768,886.56 | 2,847,673.92 | 8,583,560.16 | 2,663,622.47 |
| 其他应收款合计 | 12,107,076.4 | 11,780,116.78 | 21,720,919.97 | 21,350,932.08 |
| 存货 | 114,347,242.51 | 116,702,724.85 | 103,245,887.36 | 110,707,955.61 |
| 其他流动资产 | 6,243,237.45 | 7,287,237.86 | 7,430,998.37 | 8,741,299.47 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,971,194,180.69 | 1,944,260,056.93 | 1,987,411,570.04 | 1,969,155,915.73 |
| 非流动资产: | | | | |
| 固定资产 | 289,324,859.85 | 295,057,509.98 | 210,087,025.95 | 211,585,019.63 |
| 在建工程 | 29,544,102.31 | 21,646,451.54 | 90,942,845.74 | 83,120,162.26 |
| 使用权资产 | 3,241,986.32 | 3,689,207.78 | 894,348.93 | 1,149,884.86 |
| 无形资产 | 66,014,541.94 | 66,331,056.58 | 23,587,230.41 | 23,730,690.5 |
| 长期待摊费用 | 76,020.84 | 100,278.12 | 39,368.32 | 36,787.16 |
| 递延所得税资产 | 4,949,883.37 | 4,394,454.15 | 4,720,100.44 | 5,590,381.02 |
| 其他非流动资产 | 22,202,147.59 | 14,140,160.54 | 18,423,121.68 | 8,525,236.26 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 415,353,542.22 | 405,359,118.69 | 348,694,041.47 | 333,738,161.69 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,386,547,722.91 | 2,349,619,175.62 | 2,336,105,611.51 | 2,302,894,077.42 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 39,829,890.74 | 41,960,366.84 | 56,575,251.84 | 48,514,127.75 |
| 其中：应付票据 | 11,406,610 | 9,999,585 | 14,682,385 | 16,623,420 |
| 应付账款 | 28,423,280.74 | 31,960,781.84 | 41,892,866.84 | 31,890,707.75 |
| 合同负债 | 1,355,472.28 | 1,383,215.73 | 1,340,663.47 | 692,791.07 |
| 应付职工薪酬 | 7,017,253.95 | 13,988,900.62 | 11,582,029 | 10,275,608.43 |
| 应交税费 | 5,537,842.82 | 6,166,111.31 | 11,396,056.52 | 10,288,755.75 |
| 其他应付款合计 | 3,522,588.57 | 2,022,789.37 | 1,230,734.56 | 775,235.99 |
| 一年内到期的非流动负债 | 1,545,250.64 | 1,679,724.75 | 340,020.17 | 452,889.08 |
| 其他流动负债 | 10,057,228.89 | 3,961,730.21 | 2,428,552.04 | 2,528,988.4 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 68,865,527.89 | 71,162,838.83 | 84,893,307.6 | 73,528,396.47 |
| 非流动负债: | | | | |
| 租赁负债 | 1,287,697 | 1,601,611.53 | 529,274.98 | 626,814.49 |
| 递延收益 | 9,768,754.18 | 7,647,866.67 | 7,906,979.17 | 8,052,095.24 |
| 递延所得税负债 | 1,142,052.85 | 938,242.75 | 826,189.35 | 449,778.07 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 12,198,504.03 | 10,187,720.95 | 9,262,443.5 | 9,128,687.8 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 81,064,031.92 | 81,350,559.78 | 94,155,751.1 | 82,657,084.27 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 108,000,000 | 108,000,000 | 108,000,000 | 108,000,000 |
| 资本公积 | 1,688,056,993.19 | 1,686,279,278.15 | 1,684,490,297.98 | 1,683,177,029.98 |
| 减:库存股 | 42,000,590.49 | 42,000,590.49 | 42,000,590.49 | 31,380,551.86 |
| 其他综合收益 | 25,030.11 | - | - | - |
| 专项储备 | 5,049,670.05 | 4,436,317.49 | 4,252,782.14 | 3,759,256.68 |
| 盈余公积 | 51,579,125.31 | 49,865,214.63 | 48,702,607.45 | 44,660,697.77 |
| 未分配利润 | 494,773,462.82 | 461,688,396.06 | 438,504,763.33 | 412,020,560.58 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,305,483,690.99 | 2,268,268,615.84 | 2,241,949,860.41 | 2,220,236,993.15 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,305,483,690.99 | 2,268,268,615.84 | 2,241,949,860.41 | 2,220,236,993.15 |
| 负债和股东权益合计 | 2,386,547,722.91 | 2,349,619,175.62 | 2,336,105,611.51 | 2,302,894,077.42 |
| 公告日期 | 2025-04-28 | 2025-04-11 | 2024-10-30 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |